These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6119269)

  • 21. Arrhythmias during combined procaterol-aminophylline treatment. A review of the literature and a personal series with dynamic electrocardiography.
    Galietti F; Giorgis GE; Miravalle C; Oliaro A; Ardizzi A; Barberis S
    Panminerva Med; 1988; 30(3):173-6. PubMed ID: 2974938
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias.
    Canepa-Anson R; Dawson JR; Frankl WS; Kuan P; Sutton GC; Reuben S; Poole-Wilson PA
    Eur Heart J; 1982 Dec; 3 Suppl D():129-34. PubMed ID: 6130946
    [No Abstract]   [Full Text] [Related]  

  • 23. A warning for the treatment of hyperkalaemia with salbutamol.
    Semmekrot BA; Monnens LA
    Eur J Pediatr; 1997 May; 156(5):420. PubMed ID: 9177992
    [No Abstract]   [Full Text] [Related]  

  • 24. Sex differences in sensitivity to beta-adrenergic agonist isoproterenol in the isolated adult rat heart following prenatal protein restriction.
    Elmes MJ; Haase A; Gardner DS; Langley-Evans SC
    Br J Nutr; 2009 Mar; 101(5):725-34. PubMed ID: 18590591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y; Karmazyn M
    Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenoceptor mechanism involved in thiopental-induced potentiation of halothane-epinephrine arrhythmias in dogs.
    Kamibayashi T; Hayashi Y; Takada K; Yamatodani A; Sumikawa K; Yoshiya I
    Res Commun Mol Pathol Pharmacol; 1996 Aug; 93(2):225-34. PubMed ID: 8884993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse drug interaction involving pancuronium and aminophylline.
    Belani KG; Anderson WW; Buckley JJ
    Anesth Analg; 1982 May; 61(5):473-4. PubMed ID: 7199873
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiovascular effects: beta 2 agonists.
    Wilson AF
    J Asthma; 1990; 27(2):111-6. PubMed ID: 1971822
    [No Abstract]   [Full Text] [Related]  

  • 29. Is theophylline, aminophylline, or caffeine (methylxanthines) contraindicated in malignant hyperthermia susceptible patients?
    Flewellen EH; Nelson TE
    Anesth Analg; 1983 Jan; 62(1):115-8. PubMed ID: 6849503
    [No Abstract]   [Full Text] [Related]  

  • 30. Calcium channel blockers impair the pituitary-adrenocortical responses to central adrenergic receptors stimulation.
    Borycz J; Bugajski AJ; Gadek-Michalska A; Bugajski J
    J Physiol Pharmacol; 1993 Jun; 44(2):161-70. PubMed ID: 8102911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoproterenol exacerbates a long QT phenotype in Kcnq1-deficient neonatal mice: possible roles for human-like Kcnq1 isoform 1 and slow delayed rectifier K+ current.
    Knollmann BC; Casimiro MC; Katchman AN; Sirenko SG; Schober T; Rong Q; Pfeifer K; Ebert SN
    J Pharmacol Exp Ther; 2004 Jul; 310(1):311-8. PubMed ID: 15004216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of acute myocardial lesions by asthma drugs in rats.
    Whitehurst VE; Joseph X; Alleva FR; Vick JA; Whittaker P; Zhang J; Fry BE; Balazs T
    Toxicol Pathol; 1994; 22(1):72-6. PubMed ID: 7915431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Life-threatening heart rhythm disorders during quinine medication].
    von Düsterlho J; Homann J
    Dtsch Med Wochenschr; 1995 Apr; 120(15):542-3. PubMed ID: 7720540
    [No Abstract]   [Full Text] [Related]  

  • 36. Milrinone, a phosphodiesterase III inhibitor, antagonizes the neuromuscular blocking effect of a non-depolarizing muscle relaxant in vitro.
    Narimatsu E; Nakayama Y; Aimono M; Fujimura N; Iwasaki H; Namiki A
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):219-28. PubMed ID: 10634314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmaco-toxicologic evaluation of newly synthesized analogs of propafenone].
    Tumová I; Racanská E; Csöllei J; Ecker G; Otrusník R; Svec P
    Ceska Slov Farm; 1997 Jun; 46(3):133-6. PubMed ID: 9440950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of endogenous opioid peptides and nitric oxide in the blunted chronotropic and inotropic responses to beta-adrenergic stimulation in cirrhotic rats.
    Ebrahimi F; Tavakoli S; Hajrasouliha AR; Sadeghipour H; Dehghani M; Ahmadi SH; Dehpour AR
    Fundam Clin Pharmacol; 2006 Oct; 20(5):461-71. PubMed ID: 16968416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance to beta-adrenoceptor stimulants.
    Br Med J; 1972 Jan; 1(5793):127-8. PubMed ID: 4400056
    [No Abstract]   [Full Text] [Related]  

  • 40. A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia.
    Aizawa Y; Ueda K; Komura S; Washizuka T; Chinushi M; Inagaki N; Matsumoto Y; Hayashi T; Takahashi M; Nakano N; Yasunami M; Kimura A; Hiraoka M; Aizawa Y
    Int J Cardiol; 2005 Mar; 99(2):343-5. PubMed ID: 15749201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.